Reported 19 days ago
KKR & Co. is exploring the sale of a controlling stake in JB Chemicals & Pharmaceuticals Ltd. through a potential $750 million block trade, with possibilities to increase up to $1 billion depending on investor interest. The private equity firm currently holds nearly 54% of JB Pharma and may reduce its stake to around 25%. The company has seen a significant rise in its stock value, approximately 16% this year, and KKR intends to initiate the sale shortly, although no final decisions have been made.
Source: YAHOO